Skip to main content
. 2014 Jan 22;14:8. doi: 10.1186/1472-6947-14-8

Table 6.

Multimedia intervention outcome measures and intervention effects

Study outcome No. of studies Study Outcome measures/scale 1 Reliability tested 2 p-value 3 ES (d)
Communication
2
[70]
No. child-initiated diabetes discussions: Parent recall (one month)
No
0.0025
 
 
 
[9]
Child Satisfaction Survey:
No
 
 
 
 
 
 Felt involved in the consultation
 
<0.05
 
 
 
 
 Orthodontist understands me
 
ns
 
Satisfaction
35
[70]
User satisfaction: Instrument not described
No
ns
 
 
 
[9]
Liked the explanation: Satisfaction Survey4
No
ns
 
 
 
[69]
Satisfaction and Use Questionnaire:
No
 
 
 
 
 
 Used assigned intervention ≥ once
 
0.001
 
 
 
 
 Used intervention ‘for a long time’
 
0.0006
 
 
 
 
 Found intervention ‘easy to use’
 
ns
 
DNA rate
3
[6]
DNA at least 1 appt
N/A
ns
 
 
 
 
DNA two consecutive appts
N/A
N/K6
 
 
 
[67]
Appts kept out of total planned appointments
N/A
0.04
 
 
 
[66]
Appts kept out of total planned appointments
N/A
ns
 
Knowledge acquisition
12
[70]
Interview questions, blood glucose logbook, food exchange chart
No
ns
 
 
 
[9]
Child Short Answer Knowledge Questionnaire4:
No
 
 
 
 
 
 Three major orthodontic problems
 
<0.05
 
 
 
 
 Two orthodontic appliances/devices used
 
ns
 
 
 
 
 Three risks
 
ns
 
 
 
 
 Two instructions followed
 
ns
 
 
 
 
 Total recall and retention of information presented
 
<0.05
 
 
 
[69]
Leukemia Event Knowledge Interview [78]
Yes
0.039
 
 
 
[74]
Cystic Fibrosis Knowledge Questionnaire (adapted Quittner & Drotar (1997))7
Yes
<0.001
 
 
 
[67]
Child Knowledge of Asthma Management Questionnaire
Yes
 
0.17
 
 
[66]
Child Knowledge of Asthma Questionnaire
No
<0.001
 
 
 
[7]
Pediatric Asthma Care Knowledge Survey
No
ns
 
 
 
[68]
Child Knowledge of Asthma Management Questionnaire [67]
Yes
<0.0001
 
 
 
[8]
Asthma Knowledge Assessment
Yes
0.001
 
 
 
[65]8
Asthma Knowledge Scale (modified [79])
Yes
ns
 
 
 
 
How Much Do I Know About Sickle Cell Disease? Questionnaire (shortened [80])
Yes
ns
 
 
 
[71]
Encopresis Knowledge Questionnaire
No
ns
 
 
 
 
Virginia Encopresis/Constipation Apperception Test [81]
Yes
ns
 
Changes in self-efficacy
10
[70]
Interview questions
No
0.025
 
 
 
[9]
Child Satisfaction Survey4:
No
 
 
 
 
 
 ‘Satisfied that I know the causes’
 
ns
 
 
 
 
 ‘Satisfied that I know the treatment’
 
ns
 
 
 
 
 ‘Satisfied that I know the expected outcome’
 
ns
 
 
 
 
 ‘Satisfied that I know the risks’
 
ns
 
 
 
 
 ‘Satisfied with the explanation of the problems’
 
<0.05
 
 
 
 
 ‘Confidence in the Orthodontist’
 
ns
 
 
 
 
 ‘Not afraid of the treatment’
 
ns
 
 
 
[69]
Leukemia Children's Health Locus of Control [82]
Yes
0.005
 
 
 
[74]
Role Play Inventory of Situations and Copy Skills [83]
Yes
<0.001
 
 
 
[6]
Self-esteem Scale (shortened [84])
No
0.02
 
 
 
[67]
Child Self-efficacy Expectations Questionnaire
Yes
 
0.06
 
 
[68]
Child Self-efficacy Expectations Questionnaire [67]
Yes
<0.0001
 
 
 
[66]
Parent recall: Child attitude toward asthma care
No
ns
 
 
 
 
Parent recall: Behaviours related to asthma care
No
ns
 
 
 
[8]
Children's Asthma Locus of Control ([85], derived from [82])
Yes
0.007
0.5
 
 
[65]8
Kidcope [86]
Yes
ns
 
 
 
 
Kidcope [86]
Yes
ns
 
Health outcomes/symptoms
10
[70]
Long-term blood glucose control: HbA1c measurements
No
ns
 
 
 
[6]
Time to dry (Length of time to achieve 14 consecutive dry nights): Not described
Not stated
ns
 
 
 
 
Dry on discharge: Not described
Not stated
ns
 
 
 
 
Dry 6 months post-discharge: Questionnaire not described
Not stated
ns
 
 
 
[72]
Headache activity: Headache Index Composite calculated from Headache Diary [87]
Yes
0.04
 
 
 
 
Headache frequency, duration and severity: Pediatric Migraine Disability Assessment [88]
Yes
ns
 
 
 
[67]
Asthma symptoms: Usherwood Symptom Questionnaire [89]
Yes
0.029
 
 
 
[66]
Asthma severity: Parent recall
No
ns
 
 
 
[7]
Lung function (FEV 1 ): Instrument not described
Not stated
ns
 
 
 
 
Days of asthma symptoms since last visit:
No
<0.01
 
 
 
 
Parent recall
 
 
 
 
 
[68]
Asthma symptoms: Usherwood Symptom Questionnaire [89]
Yes
ns
 
 
 
[8]
Lung function (FEV 1 ): Micromedical Super-Spiro spirometer
Not stated
ns
 
 
 
 
Lung function (PEF): Mini-Wright Peak Flow Meter
Not stated
ns
 
 
 
[73]
Lung function (FEV 1 ): Instrument not described
Not stated
ns
 
 
 
 
Lung function (PEF): Instrument not described
Not stated
ns
 
 
 
[71]
Child Information Form:
No
 
 
 
 
 
Trips to toilet without parental prompt
 
0.109
 
 
 
 
Bowel movements in the toilet
 
0.001
 
 
 
 
Overall encopresis symptom improvement
 
0.018
 
Emergency medical visits
6
[70]
Emergency room/GP visits over past 3 months 10 : Parent recall
No
ns
 
 
 
[67]
Number of visits over past year: Parent recall
No
 
0.03
 
 
[66]
Emergency room visits: Parent recall
No
ns
 
 
 
 
Acute GP visits: Parent recall
No
ns
 
 
 
[7]
Asthma Summary Since Last Visit Questionnaire:
No
 
 
 
 
 
Urgent medical visits
 
<0.0001
 
 
 
 
Emergency room visits
 
0.0219
 
 
 
[8]
Unscheduled visits to the GP over past month: Parent recall
No
ns
 
 
 
[73]
Emergency room visits over past 6 months: Parent questionnaire and GP electronic record
Not stated
ns
 
Hospitalisation
6
[70]
Hospitalisation over past 3 months 10 : Parent recall
No
ns
 
 
[67]
Hospitalisation over past year: Parent recall
No
 
-0.14
 
 
[7]
Asthma Summary Since Last Visit Questionnaire:
No
 
 
 
 
 
Hospitalisation
 
0.0313
 
 
 
 
Days of stay in hospital
 
ns
 
 
 
[68]
Hospitalisation over past year: Parent recall
No
ns
 
 
 
[8]
Hospitalisation over past month: Parent recall
No
ns
 
    [73] Days of stay in hospital over past 6 months: Parent questionnaire and GP electronic record Not stated ns  

ES–effect size ns–not significant DNA–Did not attend Appt–appointment N/A–not applicable No.–number of FEV1–Forced expiratory volume PEV–Peak expiratory volume GP–General practitioner HbA1c–glycated haemoglobin N/K–not known.

1instruments or scales were developed by the authors, unless referenced.

2reliability of outcome measure/scale tested using Cronbach’s alpha.

3p ≤ 0.05.

4several questions could equally be categorised as ‘communication’, ‘satisfaction’ or ‘self-efficacy’. The most appropriate question(s) have been included in this Table.

5Homer, et al.[66] lacked comparison group satisfaction data, and have therefore not been included.

6not known–a chi-square test revealed no statistical significance between the 3 groups (which included a wait-list group) but no sub-analysis of the intervention and comparison group was provided.

7unable to find reference: Quittner, A.L. & Drotar, D. Controlled trial of family interventions for cystic fibrosis. [Research grant] National Institute of Health–October 1997-August 2003.

8Hazzard, et al.[65] utilised the STARBRIGHT World MI to explore it’s effect on children with asthma and sickle cell disease. The data is dealt with separately.

9significant only for those children with milder asthma symptoms.

10measured together, as emergency room/GP visits and hospitalisation.